Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Prostate|September 26, 2017
The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumorsHeather Nesbitt, Jenny Worthington, Rachel J Errington, et al.Journal of Cellular and Molecular Medicine|July 9, 2009
Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profilesJenny A Watson, Declan J McKenna, Perry Maxwell, et al.Prostate Cancer and Prostatic Diseases|June 1, 2019
Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysisCharlotte Zoe Angel, Isabel Iguacel, Amy Mullee, et al.Plos One|January 30, 2025
Investigating the miRNA-mRNA interactome of human trabecular meshwork cells treated with TGF-β1 provides insights into the pathogenesis of pseudoexfoliation glaucomaAnton W Roodnat, Chelsey Doyle, Breedge Callaghan, et al.Genomics|April 29, 2019
Serum levels of miR-199a-5p correlates with blood pressure in premature cardiovascular disease patients homozygous for the MTHFR 677C > T polymorphismSeodhna M Lynch, Mary Ward, Helene McNulty, et al.Frontiers in Oncology|June 6, 2022
A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into "Low-" and "High-Risk" Categories for Prostate CancerChristopher J McNally, Joanne Watt, Mary Jo Kurth, et al.Cells|June 26, 2024
The TGFβ Induced MicroRNAome of the Trabecular MeshworkChelsey Doyle, Breedge Callaghan, Anton W Roodnat, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant ProgressionHeather Nesbitt, Niall M Byrne, S Nicole Williams, et al.Pageof 3